Related Experiment Video
Updated: Mar 29, 2026

03:30
Author Spotlight: Advancing Pelvic Prolapse Treatment with a Non-Mesh Approach using Laparoscopic Pectopexy
Published on: October 25, 2024
2.8K
Permanent contraception for women.
Elizabeth A Micks1, Jeffrey T Jensen2
1Department of Obstetrics & Gynecology, University of Washington, 1959 NE Pacific St, Box 356460, Seattle, WA 98195-6460, USA.
Women'S Health (London, England)
|December 3, 2015
Summary
Permanent contraception offers convenience and fewer side effects for millions. This review covers female tubal occlusion methods, aiding patient choice in permanent birth control.
Area of Science:
- Reproductive Health
- Contraception Technology
Background:
- Permanent contraception is utilized by 220 million couples globally.
- Commonly chosen for convenience, ease of use, and minimal side effects.
- Tubal occlusion is a primary method for female permanent contraception.
Purpose of the Study:
- To review current female permanent contraception techniques.
- To discuss patient selection criteria for contraceptive methods.
- To compare transcervical and transabdominal tubal occlusion approaches.
Main Methods:
- Literature review of existing tubal occlusion procedures.
- Analysis of patient considerations for choosing permanent contraception.
- Categorization of techniques by surgical approach (transcervical vs. transabdominal).
Main Results:
- Multiple tubal occlusion techniques exist for permanent female contraception.
- Patient choice is influenced by factors like convenience and side effect profiles.
- Procedures can be accessed via transcervical or transabdominal routes.
Conclusions:
- A range of female permanent contraception options are available.
- Informed patient choice is crucial for selecting the appropriate tubal occlusion technique.
- Understanding procedural approaches aids in method selection for permanent birth control.
Related Concept Videos
Birth Control Methods
7.3K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
7.3K
Intrauterine Drug Delivery Systems
127
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
127
Infertility in Females
5.0K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
5.0K
Ovarian Cycle
5.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
5.2K
Secretory Phase
2.6K
The secretory phase of the menstrual cycle, spanning from day 14 to 28 in a typical 28-day cycle, is a period of significant physiological changes in the female reproductive system. This phase commences immediately after ovulation and is characterized by the preparation of the endometrium for potential embryo implantation.
Following ovulation, the corpus luteum, a temporary endocrine structure, produces progesterone and estrogens. These hormones stimulate the growth and coiling of endometrial...
Following ovulation, the corpus luteum, a temporary endocrine structure, produces progesterone and estrogens. These hormones stimulate the growth and coiling of endometrial...
2.6K
Hormonal Regulation of the Menstrual Cycle
2.3K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.3K

